| Date Field | Doc. No. | Description (Pages) |
|---|
| Oct 27, 2017 | 28 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by Clerk of Court. [471000] [15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110, 16-1283, 16-1762] [SJ] [Entered: 10/27/2017 09:40 AM] (2) |
| Jul 17, 2017 | 27 | OPINION and JUDGMENT filed. The judgment or decision is: Reversed-in-part and Remanded-in-part in 15-2066, 16-1008, 16-1009, 16-1010, 16-1110, 16-1283, 16-1762; Vacated-in-part and Remanded-in-part in 16-1109. (Precedential Opinion). (For the Court: Newman,Circuit Judge; Mayer,Circuit Judge and O'Malley,Circuit Judge). [446874] [15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110, 16-1283, 16-1762] [JAB] [Entered: 07/17/2017 10:14 AM] (25) |
| Apr 22, 2016 | 26 | Note to file: The following cases are associated:15-2066 Lead with 16-1762 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [328869] [15-2066, 16-1762] [CAB] [Entered: 04/22/2016 12:49 PM] (0) |
| Apr 21, 2016 | 22 | MOTION of Appellant Millennium Pharmaceuticals, Inc. to extend the time to 05/26/2016 at 11:59 pm to file the appellant/petitioner's principal brief. Response/Opposition is due 05/05/2016 [Consent: unopposed]. Service: 04/21/2016 by email. [328368] [William Lee] [Entered: 04/21/2016 11:09 AM] (9) |
| Apr 21, 2016 | 23 | Docketing Statement for the Appellees Wockhardt Bio AG and Wockhardt USA LLC. Service: 04/21/2016 by email. [328568] [Kristina Caggiano Kelly] [Entered: 04/21/2016 03:28 PM] (5) |
| Apr 21, 2016 | 24 | ORDER filed. The motion to consolidate [327295-2] [21] is granted. The revised official caption is reflected in the order. Appellees' response briefs are due no later than May 6, 2016. The motion for an extension of time in 2016-1762 [22] is denied as moot. Service: 04/21/2016 by clerk. [328583] [15-2066, 16-1762] [LMS] [Entered: 04/21/2016 03:40 PM] (2) |
| Apr 21, 2016 | 25 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: docketing statement (Docket No. [23]), ERROR: A certificate of interest is not a required attachment with a docketing statement. CORRECTION: A certificate of interest is already on file. If Appellees are trying to file an amended certificate of interest, it must be submitted under its own event. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [328609] [MJL] [Entered: 04/21/2016 04:12 PM] (0) |
| Apr 18, 2016 | 20 | Notice to counsel for Appellees Wockhardt Bio AG and Wockhardt USA LLC: The record of this case indicates that the Docketing Statement has not been filed. Docketing Statement due 04/28/2016. Service as of this date by Clerk of Court. [327248] [JB] [Entered: 04/18/2016 04:05 PM] (0) |
| Apr 18, 2016 | 21 | MOTION of Appellant Millennium Pharmaceuticals, Inc. and Appellees Wockhardt Bio AG and Wockhardt USA LLC to consolidate appeals (2015-2066 and 2016-1762). Response/Opposition is due 05/02/2016 [Consent: unopposed]. Service: 04/18/2016 by email. [327293] [William Lee] [Entered: 04/18/2016 04:52 PM] (16) |
| Apr 5, 2016 | 13 | Entry of appearance for Kevin Nelson as principal counsel for Appellees Wockhardt Bio AG and Wockhardt USA LLC. Service: 04/05/2016 by email. [324087] [Kristina Caggiano Kelly] [Entered: 04/05/2016 02:24 PM] (0) |
| Apr 5, 2016 | 14 | Entry of appearance for Patrick Gallagher as of counsel for Appellees Wockhardt Bio AG and Wockhardt USA LLC. Service: 04/05/2016 by email. [324090] [Kristina Caggiano Kelly] [Entered: 04/05/2016 02:26 PM] (0) |
| Apr 5, 2016 | 15 | Certificate of Interest for the Appellees Wockhardt Bio AG and Wockhardt USA LLC. Service: 04/05/2016 by email. [324092] [Kristina Caggiano Kelly] [Entered: 04/05/2016 02:27 PM] (0) |
| Apr 5, 2016 | 16 | NOTICE OF DEFICIENCY: The certificate of interest Document No. [15], attorney entry of appearance Document No. [14] , attorney entry of appearance Document No. [13] in 16-1762 does not have a proper/complete proof of service and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [324138] [JB] [Entered: 04/05/2016 03:12 PM] (0) |
| Apr 5, 2016 | 17 | Duplicate Entry of appearance for Kevin Nelson as principal counsel for Appellees Wockhardt Bio AG and Wockhardt USA LLC. Service: 04/05/2016 by email. [324186] [Kristina Caggiano Kelly] [Entered: 04/05/2016 03:46 PM] (2) |
| Apr 5, 2016 | 18 | Duplicate Entry of appearance for Patrick Gallagher as of counsel for Appellees Wockhardt Bio AG and Wockhardt USA LLC. Service: 04/05/2016 by email. [324188] [Kristina Caggiano Kelly] [Entered: 04/05/2016 03:48 PM] (2) |
| Apr 5, 2016 | 19 | Duplicate Certificate of Interest for the Appellees Wockhardt Bio AG and Wockhardt USA LLC. Service: 04/05/2016 by email. [324190] [Kristina Caggiano Kelly] [Entered: 04/05/2016 03:49 PM] (2) |
| Mar 28, 2016 | 12 | ORDER designating 16-1762 as a companion case to the set of cases in 15-2066 et al. 16-1762 shall be assigned to the same merits panel as the other appeals. Appellant's opening brief in 2016-1762 is due no later than April 28, 2016. Service as of this date by Clerk of Court. [322037] [16-1762, 15-2066] [JCA] [Entered: 03/28/2016 11:35 AM] (2) |
| Mar 24, 2016 | 1 | Appeal docketed. Received: 03/24/2016. [321396]Entry of Appearance due 04/07/2016. Certificate of Interest is due on 04/07/2016. Docketing Statement due 04/07/2016. Appellant/Petitioner's brief is due 05/23/2016. [JB] [Entered: 03/24/2016 11:27 AM] (7) |
| Mar 24, 2016 | 2 | Entry of appearance for William F. Lee as principal counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 03/24/2016 by email. [321565] [William Lee] [Entered: 03/24/2016 05:25 PM] (2) |
| Mar 24, 2016 | 3 | Entry of appearance for Lisa J. Pirozzolo as of counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 03/24/2016 by email. [321567] [Lisa Pirozzolo] [Entered: 03/24/2016 05:27 PM] (2) |
| Mar 24, 2016 | 4 | Entry of appearance for Robert M. Galvin as of counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 03/24/2016 by email. [321570] [Robert Galvin] [Entered: 03/24/2016 05:29 PM] (2) |
| Mar 24, 2016 | 5 | Entry of appearance for Emily R. Whelan as of counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 03/24/2016 by email. [321573] [Emily Whelan] [Entered: 03/24/2016 05:32 PM] (2) |
| Mar 24, 2016 | 6 | Entry of appearance for Mark C. Fleming as of counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 03/24/2016 by email. [321574] [Mark Fleming] [Entered: 03/24/2016 05:34 PM] (2) |
| Mar 24, 2016 | 7 | Entry of appearance for Jason H. Liss as of counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 03/24/2016 by email. [321575] [Jason Liss] [Entered: 03/24/2016 05:36 PM] (2) |
| Mar 24, 2016 | 8 | Entry of appearance for Anna E. Lumelsky as of counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 03/24/2016 by email. [321577] [Anna Lumelsky] [Entered: 03/24/2016 05:37 PM] (2) |
| Mar 24, 2016 | 9 | Entry of appearance for Tasha J. Bahal as of counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 03/24/2016 by email. [321578] [Tasha Bahal] [Entered: 03/24/2016 05:39 PM] (2) |
| Mar 24, 2016 | 10 | Certificate of Interest for the Appellant Millennium Pharmaceuticals, Inc.. Service: 03/24/2016 by email. [321579] [William Lee] [Entered: 03/24/2016 05:40 PM] (2) |
| Mar 24, 2016 | 11 | Docketing Statement for the Appellant Millennium Pharmaceuticals, Inc.. Service: 03/24/2016 by email. [321580] [William Lee] [Entered: 03/24/2016 05:41 PM] (4) |